MICHELI, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 9.442
EU - Europa 8.405
AS - Asia 4.589
SA - Sud America 782
Continente sconosciuto - Info sul continente non disponibili 217
AF - Africa 116
OC - Oceania 52
Totale 23.603
Nazione #
US - Stati Uniti d'America 9.211
PL - Polonia 3.686
RU - Federazione Russa 1.842
IT - Italia 1.377
SG - Singapore 1.224
CN - Cina 1.222
BR - Brasile 631
HK - Hong Kong 605
VN - Vietnam 547
IE - Irlanda 380
KR - Corea 367
SE - Svezia 228
FR - Francia 198
FI - Finlandia 192
DE - Germania 172
CA - Canada 134
BD - Bangladesh 123
ID - Indonesia 118
GB - Regno Unito 113
IN - India 109
JO - Giordania 53
NL - Olanda 52
AU - Australia 51
AR - Argentina 50
MX - Messico 35
JP - Giappone 32
EC - Ecuador 31
ES - Italia 30
IQ - Iraq 30
UA - Ucraina 27
TR - Turchia 25
ZA - Sudafrica 23
BE - Belgio 21
CH - Svizzera 21
PK - Pakistan 21
CI - Costa d'Avorio 19
MA - Marocco 17
VE - Venezuela 16
RO - Romania 15
CO - Colombia 14
JM - Giamaica 13
UZ - Uzbekistan 13
AE - Emirati Arabi Uniti 12
MY - Malesia 12
PY - Paraguay 12
NG - Nigeria 11
SA - Arabia Saudita 10
CL - Cile 9
EG - Egitto 9
PE - Perù 9
PH - Filippine 9
TN - Tunisia 9
LB - Libano 8
AZ - Azerbaigian 7
CR - Costa Rica 7
HN - Honduras 7
IL - Israele 7
KZ - Kazakistan 7
TH - Thailandia 7
AT - Austria 6
GT - Guatemala 6
KE - Kenya 6
BO - Bolivia 5
NI - Nicaragua 5
TT - Trinidad e Tobago 5
AL - Albania 4
BB - Barbados 4
BJ - Benin 4
EE - Estonia 4
NO - Norvegia 4
PR - Porto Rico 4
PT - Portogallo 4
SV - El Salvador 4
TW - Taiwan 4
BG - Bulgaria 3
DK - Danimarca 3
DZ - Algeria 3
ET - Etiopia 3
LV - Lettonia 3
OM - Oman 3
SK - Slovacchia (Repubblica Slovacca) 3
UY - Uruguay 3
AM - Armenia 2
AO - Angola 2
BH - Bahrain 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
GR - Grecia 2
HR - Croazia 2
IR - Iran 2
KG - Kirghizistan 2
LT - Lituania 2
LU - Lussemburgo 2
MU - Mauritius 2
NP - Nepal 2
QA - Qatar 2
RS - Serbia 2
SN - Senegal 2
BM - Bermuda 1
BY - Bielorussia 1
Totale 23.367
Città #
Warsaw 3.682
Santa Clara 1.767
Ashburn 1.318
Singapore 868
Fairfield 645
Hong Kong 515
San Jose 470
Dublin 376
Seoul 355
Woodbridge 318
Hefei 301
Chandler 285
Seattle 258
Council Bluffs 246
Cambridge 234
Houston 224
Milan 224
Beijing 219
Wilmington 215
Florence 209
Ho Chi Minh City 170
Altamura 143
Lawrence 142
Moscow 133
Rome 130
Los Angeles 127
Buffalo 124
Helsinki 116
Ann Arbor 108
Hanoi 103
Princeton 99
The Dalles 99
Lauterbourg 97
New York 97
Jakarta 87
Dong Ket 83
Phoenix 82
Dallas 77
Chicago 76
Munich 73
Medford 60
São Paulo 59
Mumbai 58
Philadelphia 55
Shanghai 52
Paris 48
Kent 45
Melbourne 44
San Diego 43
Boston 42
Clifton 41
Boardman 36
Naples 36
Orem 36
Frankfurt am Main 35
London 30
Lappeenranta 27
Tokyo 27
Toronto 24
Da Nang 23
Guangzhou 23
Turku 23
Rio de Janeiro 21
Tianjin 20
Abidjan 19
Montreal 19
Turin 19
Bengaluru 17
Haiphong 17
Redondo Beach 17
Salt Lake City 17
Amsterdam 16
Barcelona 16
Brooklyn 16
Miano 16
Bologna 15
Padua 15
Brussels 14
Genoa 14
Jacksonville 14
Las Vegas 14
Baghdad 13
Denver 13
Miami 13
San Francisco 13
Bari 12
Bern 12
Curitiba 12
Falls Church 12
Guayaquil 12
Norwalk 12
Palermo 12
Villejuif 12
West Jordan 12
Biên Hòa 11
Brasília 11
Campinas 11
Tashkent 11
Amman 10
Ankara 10
Totale 16.302
Nome #
Acute effect of Capparis spinosa root extracts on rat articular pain 397
Astragali radix: could it be an adjuvant for oxaliplatin-induced neuropathy? 372
Oxaliplatin Neurotoxicity Involves Peroxisome Alterations. PPARc Agonism as Preventive Pharmacological Approach 368
Bacopa monnieri as augmentation therapy in the treatment of anhedonia, preclinical and clinical evaluation 361
Atomoxetine for hoarding disorder: A pre-clinical and clinical investigation 360
Acute and subchronic antinociceptive effects of nociceptin/orphanin FQ receptor agonists infused by intrathecal route in rats 344
Anti-neuropathic effects of Rosmarinus officinalis L. terpenoid fraction: Relevance of nicotinic receptors 341
Delay of morphine tolerance by palmitoylethanolamide 337
Apoptotic Process Induced by Oxaliplatin in Rat Hippocampus Causes Memory Impairment 336
Involvement of the N/OFQ-NOP system in rat morphine antinociceptive tolerance: Are astrocytes the crossroad? 330
Adipose-derived stem cells decrease pain in a rat model of oxaliplatin-induced neuropathy: Role of VEGF-A modulation 326
The Versatile 2-Substituted Imidazoline Nucleus as a Structural Motif of Ligands Directed to the Serotonin 5-HT1A Receptor 326
Acute visceral pain relief mediated by A(3)AR agonists in rats: involvement of N-type voltage-gated calcium channels 322
A rat model of FOLFOX-induced neuropathy: effects of oral dimiracetam in comparison with duloxetine and pregabalin 315
Characterisation of the novel mixed Mu-NOP peptide ligand dermorphin-N/OFQ (DeNo) 311
Different apoptotic pathways activated by oxaliplatin in primary astrocytes vs. colo-rectal cancer cells 307
Selective HCN1 block as a strategy to control oxaliplatin-induced neuropathy 300
Astragalus membranaceus and oxaliplatin-induced neuropathy: pain relief and prevention of nervous tissue modifications. 297
Synthesis and Biological Evaluation of Novel Neuroprotective Pyridazine Derivatives as Excitatory Amino Acid Transporter 2 (EAAT2) Activators 293
Low dose native type II collagen prevents pain in a rat osteoarthritis model 292
α2 Adrenoceptor: a Target for Neuropathic Pain Treatment 291
Effects of a water extract of Lepidium meyenii root in different models of persistent pain in rats 287
PPAR-γ Impairment Alters Peroxisome Functionality in Primary Astrocyte Cell Cultures 287
Photobiomodulation therapy by NIR laser in persistent pain: an analytical study in the rat 286
Visceral sensitivity modulation by faecal microbiota transplantation: the active role of gut bacteria in pain persistence 265
Effect of glucoraphanin and sulforaphane against chemotherapy-induced neuropathic pain: Kv7 potassium channels modulation by H2 S release in vivo. 259
Pain relieving and protective effects of Astragalus hydroalcoholic extract in rat arthritis models 258
Effects of natural and synthetic isothiocyanate-based H2S-releasers against chemotherapy-induced neuropathic pain: Role of Kv7 potassium channels 257
Coronaridine congeners decrease neuropathic pain in mice and inhibit α9α10 nicotinic acetylcholine receptors and CaV2.2 channels 245
Synergic stimulation of serotonin 5-HT1A receptor and α2-adrenoceptors for neuropathic pain relief: Preclinical effects of 2-substituted imidazoline derivatives 241
Phaseolus vulgaris L. Extract: Alpha-Amylase Inhibition against Metabolic Syndrome in Mice . 241
Pain relieving effect of-NSAIDS-CAIs hybrid molecules: Systemic and intra-articular treatments against rheumatoid arthritis 229
Effect of Vitis vinifera hydroalcoholic extract against oxaliplatin neurotoxicity: in vitro and in vivo evidence 227
Intra-articular mucilages: behavioural and histological evaluations for a new model of articular pain. 224
Effect of NIR laser therapy by MLS-MiS source against neuropathic pain in rats: in vivo and ex vivo analysis. 224
Anti-Hyperalgesic Efficacy of Acetyl L-Carnitine (ALCAR) Against Visceral Pain Induced by Colitis: Involvement of Glia in the Enteric and Central Nervous System 223
Eruca sativa Meal against Diabetic Neuropathic Pain: An H2S-Mediated Effect of Glucoerucin 222
Effects of the neutrophil elastase inhibitor EL-17 in rat adjuvant-induced arthritis. 220
Efficacy of a vegetal mixture composed of Zingiber officinale, Echinacea purpurea, and Centella asiatica in a mouse model of neuroinflammation: In vivo and ex vivo analysis 219
Chalcogenides-incorporating carbonic anhydrase inhibitors concomitantly reverted oxaliplatin-induced neuropathy and enhanced antiproliferative action 219
Pain Relieving Eect of-NSAIDs-CAIs Hybrid Molecules: Systemic and Intra-Articular Treatments against Rheumatoid Arthritis 217
Intranasal Low-Dose Naltrexone Against Opioid Side Effects: A Preclinical Study 215
Carbonic Anhydrase IV Selective Inhibitors Counteract the Development of Colitis-Associated Visceral Pain in Rats 212
Effects of Ultramicronized N-Palmitoylethanolamine Supplementation on Tramadol and Oxycodone Analgesia and Tolerance Prevention 204
Effects of the combination of β-hydroxy-β-methyl butyrate and R(+) lipoic acid in a cellular model of sarcopenia 203
Deepening the Mechanisms of Visceral Pain Persistence: An Evaluation of the Gut-Spinal Cord Relationship 202
Synthesis and evaluation of carbonic anhydrase inhibitors with carbon monoxide releasing properties for the management of rheumatoid arthritis 199
Neuronal alarmin IL-1α evokes astrocyte-mediated protective signals: Effectiveness in chemotherapy-induced neuropathic pain 198
Ultramicronized N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception 197
Oxidative, Metabolic, And Apoptotic Responses of Schwann Cells to High Glucose Levels 195
Efficacy of isothiocyanate-based compounds on different forms of persistent pain. 194
The α9α10 nicotinic receptor antagonist α-conotoxin RgIA prevents neuropathic pain induced by oxaliplatin treatment. 193
Peroxisome determination in optical microscopy: a useful tool derived by a simplification of an old ultrastructural technique. 191
Restorative and pain-relieving effects of fibroin in preclinical models of tendinopathy 191
Ibogalogs decrease neuropathic pain in mice through a mechanism involving crosstalk between 5-HT2A and mGlu2 receptors 187
Efficacy of Posidonia oceanica Extract against Inflammatory Pain: In Vivo Studies in Mice 187
Escinosome thermosensitive gel optimizes efficacy of CAI-CORM in a rat model of rheumatoid arthritis 186
Inhibition of Monoacylglycerol Lipase by NSD1819 as an Effective Strategy for the Endocannabinoid System Modulation against Neuroinflammation-Related Disorders 185
Role of enteric glia as bridging element between gut inflammation and visceral pain consolidation during acute colitis in rats 185
Oxaliplatin evokes P2X7-dependent glutamate release in the cerebral cortex: A pain mechanism mediated by Pannexin 1 184
Bioisosteric Development of Multitarget Nonsteroidal Anti-Inflammatory Drug-Carbonic Anhydrases Inhibitor Hybrids for the Management of Rheumatoid Arthritis 184
Pomegranate mesocarp against colitis-induced visceral pain in rats: Effects of a decoction and its fractions 184
The Efficacy of Camelina sativa Defatted Seed Meal against Colitis-Induced Persistent Visceral Hypersensitivity: The Relevance of PPAR α Receptor Activation in Pain Relief 182
Researching new therapeutic approaches for abdominal visceral pain treatment: Preclinical effects of an assembled system of molecules of vegetal origin 182
Pain Relieving and Neuroprotective Effects of Non-opioid Compound, DDD-028, in the Rat Model of Paclitaxel-Induced Neuropathy 181
Carbonic anhydrase inhibition for the management of cerebral ischemia: in vivo evaluation of sulfonamide and coumarin inhibitors 180
Beneficial Effects of Eruca sativa Defatted Seed Meal on Visceral Pain and Intestinal Damage Resulting from Colitis in Rats 180
Inhibitors of Mitochondrial Human Carbonic Anhydrases VA and VB as a Therapeutic Strategy against Paclitaxel-Induced Neuropathic Pain in Mice 179
Protective and Pain-Killer Effects of AMC3, a Novel N-Formyl Peptide Receptors (FPRs) Modulator, in Experimental Models of Rheumatoid Arthritis 179
Comparative assessment of the activity of racemic and dextrorotatory forms of thioctic (alpha-lipoic) acid in low back pain: preclinical and clinical evidences, from an open randomized trial. 177
Treatment of Non-Alcoholic Steatosis: Preclinical Study of a New Nutraceutical Multitarget Formulation. 174
Nanostructured lipid carriers for oral delivery of silymarin: improving its absorption and in vivo efficacy in type 2 diabetes and metabolic syndrome model 172
Intra-articular route for the system of molecules 14g1862 from centella asiatica: Pain relieving and protective effects in a rat model of osteoarthritis 172
VEGF-A/VEGFR-1 signalling and chemotherapy-induced neuropathic pain: therapeutic potential of a novel anti-VEGFR-1 monoclonal antibody 171
Non-hallucinogenic compounds derived from iboga alkaloids alleviate neruopathic and visceral pain in mice through a mechanism involving 5-HT2A receptor activation 169
Serotonergic modulation in neuropathy induced by oxaliplatin: Effect on the 5HT2C receptor 169
Broad-spectrum neuroprotection exerted by DDD-028 in a mouse model of chemotherapy-induced neuropathy 167
alpha-Conotoxin RgIA protects against the development of nerve injury-induced chronic pain and prevents both neuronal and glial derangement. 166
Posidonia oceanica (L.) Delile Is a Promising Marine Source Able to Alleviate Imiquimod-Induced Psoriatic Skin Inflammation 163
Naturally occurring glucosinolates and isothiocyanates as a weapon against chronic pain: potentials and limits 159
The active second-generation proteasome inhibitor oprozomib reverts the oxaliplatin-induced neuropathy symptoms 156
The histamine h4 receptor participates in the anti-neuropathic effect of the adenosine a3 receptor agonist ib-meca: Role of cd4+ t cells 154
Beneficial Effect of H2S-Releasing Molecules in an In Vitro Model of Sarcopenia: Relevance of Glucoraphanin 154
Nociceptin/orphanin FQ receptor and pain: Feasibility of the fourth opioid family member 153
The Anti-Arthritic Efficacy of Khellin Loaded in Ascorbyl Decanoate Nanovesicles after an Intra-Articular Administration 149
Phaseolus vulgaris extract ameliorates high-fat diet-induced colonic barrier dysfunction and inflammation in mice by regulating peroxisome proliferator-activated receptor expression and butyrate levels 148
Ultramicronized N-palmitoylethanolamine associated with analgesics: Effects against persistent pain 145
Glia role in oxaliplatin-induced neuropathic pain. 145
Functional Selectivity and Antinociceptive Effects of a Novel KOPr Agonist 144
Antinociceptive Action of Thymoquinone-Loaded Liposomes in an In Vivo Model of Tendinopathy 142
The Use of the Selective Imidazoline I1 Receptor Agonist Carbophenyline as a Strategy for Neuropathic Pain Relief: Preclinical Evaluation in a Mouse Model of Oxaliplatin-Induced Neurotoxicity 138
Phenyl(thio)phosphon(amid)ate Benzenesulfonamides as Potent and Selective Inhibitors of Human Carbonic Anhydrases II and VII Counteract Allodynia in a Mouse Model of Oxaliplatin-Induced Neuropathy 138
Development of Hydrogen Sulfide-Releasing Carbonic Anhydrases IX- and XII-Selective Inhibitors with Enhanced Antihyperalgesic Action in a Rat Model of Arthritis 137
Preventing social defeat stress-induced behavioural and neurochemical alterations by repeated treatment with a mix of Centella asiatica, Echinacea purpurea and Zingiber officinale standardized extracts 137
In vitro and in vivo characterization of the bifunctional u and o opioid receptor ligand UFP-505 137
Intrathecal administration of nociceptin/orphanin FQ receptor agonists in rats: A strategy to relieve chemotherapy-induced neuropathic hypersensitivity 135
Ultramicronized N-palmitoylethanolamine contributes to morphine efficacy against neuropathic pain: implication of mast cells and glia 134
Novel Insights on CAI-CORM Hybrids: Evaluation of the CO Releasing Properties and Pain-Relieving Activity of Differently Substituted Coumarins for the Treatment of Rheumatoid Arthritis 132
Development of a stable oral pediatric solution of hydrochlorothiazide by the combined use of cyclodextrins and hydrophilic polymers 130
Pain Modulation in WAG/Rij Epileptic Rats (A Genetic Model of Absence Epilepsy): Effects of Biological and Pharmacological Histone Deacetylase Inhibitors 127
Totale 21.809
Categoria #
all - tutte 63.363
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.363


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022577 0 0 0 37 24 53 24 62 56 70 89 162
2022/20231.606 155 395 90 54 78 264 230 89 151 21 50 29
2023/2024734 32 70 114 44 59 81 33 128 19 78 52 24
2024/20255.667 199 555 367 764 1.433 746 259 333 222 213 283 293
2025/20267.598 725 897 729 828 778 278 751 398 562 521 345 786
2026/20271.181 338 217 605 21 0 0 0 0 0 0 0 0
Totale 23.603